New CEO at Roche's Pharma Division
31.08.2012 - Swiss drug giant Roche AG has filled the leadership gap at its pharma division after its former head Pascal Soriot left the company to become CEO of British-Swedish pharma major AstraZeneca.
From 1 September, Daniel O’Day, currently COO at Roche Diagnostics, will step in. O’Day will be succeeded by Roland Diggelmann, currently Head of the Asia-Pacific Region within Roche Diagnostics who has been appointed as a new member of the Executive Committee by the Board of Directors. Daniel O’Day began his career in 1987 at Roche in the U.S. Pharmaceuticals organisation in Sales and Marketing. Following that, he held various positions in Roche Pharma in Switzerland, Japan, and Denmark. In 2006, O’Day joined Roche Diagnostics and became Head of the business area „Molecular Diagnostics“. On January 1 2010 he was appointed Chief Operating Officer for Roche’s global diagnostics business.http://www.european-biotechnology-news.com/people/bio-people/2012-2/oday-roche.html